Rena Malik, MD Podcast Moment: How One MRI Can Lead to Years of Unnecessary Treatment
Jan 28, 2026
A deep dive into whole-body MRI screening trade-offs, including whether to use contrast and who truly benefits. The conversation spotlights overdiagnosis, incidental findings, and how harmless-looking results can trigger harmful cascades of care. Examples include thyroid and prostate screening and how sensitive imaging can overrepresent indolent disease.
AI Snips
Chapters
Transcript
Episode notes
Use Contrast Only When Risk Justifies It
- Avoid routine contrast use in whole-body MRIs for average-risk people because it raises harms from IVs and rare reactions.
- Reserve contrast when pretest probability of disease is high, such as hereditary cancer syndromes.
Overdiagnosis Can Create A False Sense Of Benefit
- Detecting common indolent findings creates an illusion of benefit because treatment increases while mortality stays the same.
- The thyroid screening surge raised incidence massively without reducing deaths.
Which Cancers Are Screenable?
- Screening best targets cancers with intermediate progression, not very aggressive or very indolent tumors.
- Whole-body MRI in low-risk people mainly finds indolent lesions and causes harms from follow-up.